Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
life sciences
4
×
medicare
4
×
national blog main
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
amgen
biotech
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
merck
national
national top stories
new york blog main
new york top stories
novartis
pfizer
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
venture capital
wisconsin blog main
wisconsin top stories
biogen
cancer
deals
diagnostics
funding
gene therapy
immunotherapy
What
patients
4
×
bio
drug
roundup
healthcare
therapy
acquisitions
advantages
albert
bar
becker
biggest
billions
bourla
brings
ceo
company
crispr
daunting
developers
dollars
eaton
expect
firms
future
gamble
gene
impact
imports
life
maker
maps
market
markets
maze
measured
medco’s
michael
millions
mindmaze
Language
unknown
unset
Current search:
patients
×
medicare
×
" life sciences "
×
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
Virtual Physical Therapy Firms Reflexion and MindMaze Probe Markets